In a surprising turn of events, a significant HIV research project targeting Black and Hispanic gay men has been given a second chance after a court ruling. However, the scientific community remains on edge due to ongoing political interference. The National Institutes of Health (NIH) initially canceled the study, along with hundreds of others, citing a shift in age...
A major breakthrough in HIV prevention has just been approved by the FDA. The drug, called Yeztugo, is based on research done by a biochemist from the University of Utah. This drug is special because it can protect people from HIV for a long time, up to six months. It works by stopping the virus from building its protective shell, which is crucial for it to spread. ...
The fight against HIV just got a new ally. It is the same technology that made COVID-19 vaccines possible. mRNA, or messenger RNA, is a set of instructions for genes. It is not a new discovery. It has been around for a while. It is only now that it is being used in new ways. Scientists in Australia have found a way to use mRNA to target HIV. This is big news. ...
In many developing nations, there's a significant problem. Young people, aged 10 to 24, are often not included in HIV research. This is a big deal because it makes it tough to figure out how to help them. These young adults and adolescents are often left in the dark when it comes to understanding and improving their health. The main issue? Getting informed consent f...
The Department of Government Efficiency task force recently announced a massive cut of $109 million in federal grants to UCLA. This decision has far-reaching consequences, especially for HIV research and patient care. One of the most affected areas is a study that had enrolled over 200 HIV-positive individuals, which was abruptly halted. This abrupt stop has left man...
When it comes to making decisions about sharing individual genetic research results, people living with HIV have strong opinions. A study in Uganda asked 221 people receiving HIV care what role they wanted in deciding how to get information from genetic research. Most participants (122, 55. 2%) wanted to be part of the decision-making process with researchers. Anothe...
The world of medicine is always on the hunt for new ways to help the human body. There is an interesting case of scientists working with what can be described as a vaccine. This unique vaccine is made from what they call a "HIV envelope glycoprotein (Env) immunogens. " by stabilising it which is a fancy word for making it stay the same. The study looked at ho...